Custom bicyclic peptides designed to lock bioactive loops into defined architectures for improved rigidity, target selectivity, protease resistance, and high-affinity molecular recognition.
Bicyclic peptides are peptide molecules containing two interconnected ring systems. Compared with linear or monocyclic peptides, the additional constraint can reduce conformational flexibility and help present binding loops in a more defined, target-ready orientation.
Bio-Synthesis supports custom bicyclic peptide synthesis for research, screening, hit validation, affinity maturation, conjugation, and structure–activity studies. Bicyclic constructs can be designed using disulfide pairing, amide cyclization, side-chain bridging, or synthetic scaffold/linker strategies depending on the sequence and intended application.
Also exploring related formats? See cyclic peptides, macrocyclic peptides, and advanced peptide synthesis.
Two loops can lock the peptide into a defined binding geometry and reduce nonproductive conformers.
Controlled loop presentation can improve specificity for receptors, enzymes, and protein–protein interfaces.
Sequences, linkages, handles, purification targets, and analytical packages can be tailored to the project.
Conformational restriction can improve resistance to proteolysis and reduce flexible degradation-prone states.
Preorganized loops can lower the conformational penalty during binding and support stronger target engagement.
A two-loop scaffold can display recognition elements with high spatial precision.
Bicyclic designs may incorporate labels, linkers, click handles, biotin, or payload attachment points.
Use this table to define the bicyclic peptide requirements for quote preparation, feasibility review, and synthesis planning.
Designed with cysteine pairs or cysteine-rich motifs that form two constrained loops. Useful when reversible redox chemistry or native-like disulfide topology is part of the design.
Multiple peptide handles are connected through a synthetic core or linker to generate a compact two-loop architecture with predictable display.
Amide-based constraints can provide robust covalent ring closure and may be selected when enhanced chemical stability is desired.
Mixed strategies combine disulfide, amide, thioether, click, or linker-based chemistry for specialized topologies and downstream workflows.
Bio-Synthesis provides custom bicyclic peptide synthesis services for two-ring constrained peptide scaffolds, cysteine-rich peptides, drug-discovery binders, inhibitor candidates, and conjugation-ready bicyclic constructs. Projects can be designed around disulfide formation, amide/lactam cyclization, thioether bridging, click chemistry, or scaffold-based center-core architectures.
Why this matters: Bicyclic peptides are often used when linear or monocyclic peptides do not provide enough target engagement, protease resistance, or loop-level conformational control. The right scaffold and bridge chemistry can improve display of binding motifs while preserving residues required for activity.
Bicyclic peptide scaffolds can be used to evaluate constrained binding motifs, identify high-affinity target binders, and support early hit validation.
Loop spacing, bridge chemistry, terminal caps, solubility tags, and linker design can be adjusted to improve potency, selectivity, and assay performance.
Two-loop peptide scaffolds can help address protein–protein interactions, shallow binding pockets, enzyme surfaces, receptors, and other challenging recognition sites.
Matched linear, monocyclic, macrocyclic, and bicyclic analogs can be prepared to evaluate the effect of constraint on activity and stability.
Peptides can be prepared with biotin, fluorescent dyes, click handles, or spacers for binding assays, pull-down studies, imaging, or immobilization.
LC-MS, analytical HPLC, CoA documentation, and optional architecture confirmation support confidence in complex bicyclic peptide projects.
Each project can be reviewed for ring placement, scaffold compatibility, hydrophobicity, cysteine pattern, solubility risk, and purification feasibility.
Support for disulfide, amide/lactam, thioether, click-compatible, and scaffolded bicyclic peptide approaches allows the synthesis route to match the application.
Analytical HPLC, LC-MS identity confirmation, CoA documentation, and optional mapping help verify purity and intended architecture.
A bicyclic peptide project usually starts with the target sequence and desired loop topology, then moves through synthesis, controlled cyclization, purification, and confirmation.
Sequence, anchor residues, protected groups, and target topology are evaluated.
Peptide is assembled with the required residues, handles, and orthogonal functionality.
One or more controlled bridge-forming steps produce the intended bicyclic architecture.
Preparative HPLC or project-appropriate purification is used to meet purity goals.
LC–MS, HPLC purity, CoA, and optional mapping support final documentation.
Bicyclic peptides are valuable in peptide drug discovery because they combine antibody-like binding surface potential with peptide-scale synthetic accessibility. Their constrained two-loop architecture can support high-affinity molecular recognition, receptor targeting, enzyme inhibition, and selective binding to difficult protein surfaces.
Rigid loop presentation for receptor ligands, enzyme binders, and affinity reagents.
Constrained motifs can help mimic complex binding surfaces that are hard to address with small molecules.
Two-loop architectures may improve potency and selectivity for enzymes or signaling proteins.
Bicyclic and cysteine-rich scaffolds are used in studies of stable peptide-based antimicrobial candidates.
Labels, dyes, and biotin handles can be incorporated for assay, imaging, or immobilization formats.
Bicyclic binders can be prepared with linkers or handles for payload, surface, or carrier conjugation.
Bicyclic peptides often require more careful confirmation than simple linear peptides because the same sequence can potentially form different regioisomers, oxidation states, or partially cyclized products. The analytical plan should match the complexity of the architecture and the intended application.
Planning tip: If your bicycle contains multiple cysteines, orthogonal handles, or a complex scaffold, request the appropriate mapping or confirmation strategy at the quoting stage.
A bicyclic peptide is a peptide containing two interconnected rings. The rings can be formed by disulfide bonds, amide/lactam linkages, thioether bridges, click chemistry, or synthetic scaffold linkers.
Choose a bicyclic format when a single ring does not provide enough conformational control, when you need two defined binding loops, or when affinity and selectivity depend on precise spatial presentation.
Often yes. The extra constraints can reduce protease-sensitive conformations and improve structural persistence, though final stability depends on sequence, bridge chemistry, and assay environment.
Yes. Cysteine-rich sequences can be prepared with defined oxidation and purification strategies. Complex disulfide patterns may require additional mapping or confirmation.
Yes. Common options include biotin, fluorescent dyes, PEG/spacers, cysteine handles, azide/alkyne click handles, and payload-ready linkers.
Send the sequence, intended ring architecture, anchor residues or bridge chemistry, purity and scale, desired QC, modifications, and any assay or target constraints that may affect design.
Yes. Bicyclic peptides can be designed around center-core scaffold chemistries that connect multiple peptide handles and define two-loop geometry. Scaffold selection depends on sequence, spacing, solubility, and the intended assay.
Yes. Azide, alkyne, and other click-compatible handles can be incorporated when planned into the design. These are useful for labeling, immobilization, payload attachment, and follow-up conjugation workflows.
Helix-stabilized peptides using hydrocarbon stapling to improve cell permeability, binding affinity, and protease resistance.
Large ring peptide scaffolds designed for flexible yet constrained binding, commonly used in drug discovery and screening.
Alpha-helical peptides engineered for structural stability, receptor targeting, and protein–protein interaction studies.
CONTACT
Share your sequence, proposed ring architecture, preferred bridge chemistry, target purity/scale, and intended application. We can recommend a practical synthesis and QC strategy for your bicyclic peptide project.
Tip: If the peptide is long, hydrophobic, cysteine-rich, or contains non-natural residues, include that context so the design can be routed to the right synthesis strategy.
Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.